GLP-1s Took Eli Lilly To $1 Trillion. CEO Dave Ricks Is Betting Billions He Can Do It Again
CEO Dave Ricks built Eli Lilly into the first $1 trillion pharma company with its blockbuster weight-loss and diabetes drugs.
But with more than 60% of revenue coming from them, the drug giant faces the risks of its own success.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.forbes.com — the content belongs to Forbes.